[Translation] A multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of induction therapy with risankizumab in patients with moderately to severely active Crohn's disease who failed prior biologic therapy
研究M15-991的目的是评估患有中度至重度活动性克罗恩病(CD)的受试者在诱导治疗期间接受Risankizumab治疗与安慰剂治疗相比的疗效和安全性。
[Translation] The purpose of study M15-991 was to evaluate the efficacy and safety of risankizumab compared to placebo in subjects with moderately to severely active Crohn's disease (CD) during induction therapy.